{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:07:39Z","timestamp":1770350859034,"version":"3.49.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["RO1HL145985"],"award-info":[{"award-number":["RO1HL145985"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-01349-w","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T15:35:43Z","timestamp":1767195343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular insights in HIV-associated cardiac dysfunction"],"prefix":"10.1038","volume":"6","author":[{"given":"Mar\u00eda","family":"Valero-Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eng Leng","family":"Saw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6122-7511","authenticated-orcid":false,"given":"Adam C.","family":"Gower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman","family":"Srinivasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markella V.","family":"Zanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mabel","family":"Toribio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven K.","family":"Grinspoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8442-9362","authenticated-orcid":false,"given":"Flora","family":"Sam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"1349_CR1","unstructured":"UNAIDS. UNAIDS data 2022. (UNAIDS, 2023)."},{"key":"1349_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jacc.2018.05.031","volume":"72","author":"RS Rosenson","year":"2018","unstructured":"Rosenson, R. S. & Kaul, R. Cardiovascular outcomes in persons with HIV and heart failure: medication class or suboptimal viral suppression? J. Am. Coll. Cardiol. 72, 531\u2013533 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1349_CR3","doi-asserted-by":"publisher","first-page":"e2327584","DOI":"10.1001\/jamanetworkopen.2023.27584","volume":"6","author":"LF Collins","year":"2023","unstructured":"Collins, L. F. et al. Aging-related comorbidity burden among women and men with or at-risk for HIV in the US, 2008-2019. JAMA Netw. Open 6, e2327584 (2023).","journal-title":"JAMA Netw. Open"},{"key":"1349_CR4","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nrcardio.2014.167","volume":"11","author":"MV Zanni","year":"2014","unstructured":"Zanni, M. V., Schouten, J., Grinspoon, S. K. & Reiss, P. Risk of coronary heart disease in patients with HIV infection. Nat. Rev. Cardiol. 11, 728\u2013741 (2014).","journal-title":"Nat. Rev. Cardiol."},{"key":"1349_CR5","doi-asserted-by":"publisher","first-page":"e26123","DOI":"10.1002\/jia2.26123","volume":"26","author":"PF Rebeiro","year":"2023","unstructured":"Rebeiro, P. F. et al. Incidence of cardiometabolic outcomes among people living with HIV-1 initiated on integrase strand transfer inhibitor versus non-integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States. J. Int AIDS Soc. 26, e26123 (2023).","journal-title":"J. Int AIDS Soc."},{"key":"1349_CR6","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1016\/S2352-3018(22)00094-7","volume":"9","author":"B Neesgaard","year":"2022","unstructured":"Neesgaard, B. et al. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium. Lancet HIV 9, e474\u2013e485 (2022).","journal-title":"Lancet HIV"},{"key":"1349_CR7","doi-asserted-by":"publisher","first-page":"e723","DOI":"10.1016\/S2352-3018(23)00233-3","volume":"10","author":"SM Rein","year":"2023","unstructured":"Rein, S. M. et al. Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL collaboration and the antiretroviral therapy cohort collaboration. Lancet HIV 10, e723\u2013e732 (2023).","journal-title":"Lancet HIV"},{"key":"1349_CR8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/cid\/ciad286","volume":"77","author":"B Surial","year":"2023","unstructured":"Surial, B. et al. Impact of integrase inhibitors on cardiovascular disease events in people with human immunodeficiency virus starting antiretroviral therapy. Clin. Infect. Dis. 77, 729\u2013737 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"1349_CR9","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","volume":"389","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod, M. N. et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N. Engl. J. Med 389, 1069\u20131084 (2023).","journal-title":"N. Engl. J. Med"},{"key":"1349_CR10","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1161\/CIRCULATIONAHA.113.004574","volume":"129","author":"J Remick","year":"2014","unstructured":"Remick, J. et al. Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research. Circulation 129, 1781\u20131789 (2014).","journal-title":"Circulation"},{"key":"1349_CR11","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1093\/eurheartj\/ehr398","volume":"33","author":"K Sliwa","year":"2012","unstructured":"Sliwa, K. et al. Contribution of the human immunodeficiency virus\/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort. Eur. Heart J. 33, 866\u2013874 (2012).","journal-title":"Eur. Heart J."},{"key":"1349_CR12","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/eurheartj\/ehs471","volume":"34","author":"E Cerrato","year":"2013","unstructured":"Cerrato, E. et al. Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. Eur. Heart J. 34, 1432\u20131436 (2013).","journal-title":"Eur. Heart J."},{"key":"1349_CR13","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/jamacardio.2017.0264","volume":"2","author":"MS Freiberg","year":"2017","unstructured":"Freiberg, M. S. et al. Association between HIV infection and the risk of heart failure with reduced ejection fraction and preserved ejection fraction in the antiretroviral therapy era: results from the veterans aging cohort study. JAMA Cardiol. 2, 536\u2013546 (2017).","journal-title":"JAMA Cardiol."},{"key":"1349_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12968-022-00901-0","volume":"24","author":"PS Robbertse","year":"2022","unstructured":"Robbertse, P. S., Doubell, A. F., Lombard, C. J., Talle, M. A. & Herbst, P. G. Evolution of myocardial oedema and fibrosis in HIV infected persons after the initiation of antiretroviral therapy: a prospective cardiovascular magnetic resonance study. J. Cardiovasc Magn. Reson 24, 72 (2022).","journal-title":"J. Cardiovasc Magn. Reson"},{"key":"1349_CR15","doi-asserted-by":"crossref","unstructured":"Papamanoli, A., Muncan, B., Yoo, J., Psevdos, G. & Kalogeropoulos, A. P. Human immunodeficiency virus infection-associated cardiomyopathy and heart failure. J. Pers. Med. 12, 1760 (2022).","DOI":"10.3390\/jpm12111760"},{"key":"1349_CR16","doi-asserted-by":"publisher","first-page":"e004312","DOI":"10.1161\/CIRCHEARTFAILURE.117.004312","volume":"11","author":"R Scherzer","year":"2018","unstructured":"Scherzer, R. et al. Association of biomarker clusters with cardiac phenotypes and mortality in patients with HIV infection. Circ. Heart Fail 11, e004312 (2018).","journal-title":"Circ. Heart Fail"},{"key":"1349_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S1359-6101(96)00043-3","volume":"7","author":"DL Mann","year":"1996","unstructured":"Mann, D. L. Stress activated cytokines and the heart. Cytokine Growth Factor Rev. 7, 341\u2013354 (1996).","journal-title":"Cytokine Growth Factor Rev."},{"key":"1349_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijcard.2006.11.143","volume":"120","author":"JJ Monsuez","year":"2007","unstructured":"Monsuez, J. J., Escaut, L., Teicher, E., Charniot, J. C. & Vittecoq, D. Cytokines in HIV-associated cardiomyopathy. Int J. Cardiol. 120, 150\u2013157 (2007).","journal-title":"Int J. Cardiol."},{"key":"1349_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jacc.2016.09.977","volume":"69","author":"P Manga","year":"2017","unstructured":"Manga, P., McCutcheon, K., Tsabedze, N., Vachiat, A. & Zachariah, D. HIV and nonischemic heart disease. J. Am. Coll. Cardiol. 69, 83\u201391 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1349_CR20","first-page":"309","volume":"72","author":"N Goldblum","year":"1990","unstructured":"Goldblum, N. et al. Susceptibility to HIV-1 infection of a human B-lymphoblastoid cell line, DG75, transfected with subgenomic DNA fragments of Epstein-Barr virus. Dev. Biol. Stand 72, 309\u2013313 (1990).","journal-title":"Dev. Biol. Stand"},{"key":"1349_CR21","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1089\/088922201753197097","volume":"17","author":"QN Liu","year":"2001","unstructured":"Liu, Q. N. et al. Essential role of HIV type 1-infected and cyclooxygenase 2-activated macrophages and T cells in HIV type 1 myocarditis. AIDS Res. Hum. Retroviruses 17, 1423\u20131433 (2001).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"1349_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1385\/CT:4:2:097","volume":"4","author":"M Fiala","year":"2004","unstructured":"Fiala, M. et al. HIV-1 induces cardiomyopathyby cardiomyocyte invasion and gp120, Tat, and cytokine apoptotic signaling. Cardiovasc. Toxicol. 4, 97\u2013107 (2004).","journal-title":"Cardiovasc. Toxicol."},{"key":"1349_CR23","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1161\/hc3401.093154","volume":"104","author":"N Sivasubramanian","year":"2001","unstructured":"Sivasubramanian, N. et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104, 826\u2013831 (2001).","journal-title":"Circulation"},{"key":"1349_CR24","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1161\/01.CIR.0000165117.71483.0C","volume":"111","author":"M Li","year":"2005","unstructured":"Li, M. et al. p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart. Circulation 111, 2494\u20132502 (2005).","journal-title":"Circulation"},{"key":"1349_CR25","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1001\/jamacardio.2016.0846","volume":"1","author":"MV Zanni","year":"2016","unstructured":"Zanni, M. V. et al. Effects of antiretroviral therapy on immune function and arterial inflammation in treatment-naive patients with human immunodeficiency virus infection. JAMA Cardiol. 1, 474\u2013480 (2016).","journal-title":"JAMA Cardiol."},{"key":"1349_CR26","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1210\/jc.2015-1461","volume":"100","author":"S Srinivasa","year":"2015","unstructured":"Srinivasa, S. et al. RAAS activation is associated with visceral adiposity and insulin resistance among HIV-infected patients. J. Clin. Endocrinol. Metab. 100, 2873\u20132882 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1349_CR27","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1093\/infdis\/jiw392","volume":"214","author":"S Srinivasa","year":"2016","unstructured":"Srinivasa, S. et al. Effects of sodium restriction on activation of the renin-angiotensin-aldosterone system and immune indices during HIV infection. J. Infect. Dis. 214, 1336\u20131340 (2016).","journal-title":"J. Infect. Dis."},{"key":"1349_CR28","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1210\/jc.2017-02198","volume":"103","author":"CA Murphy","year":"2018","unstructured":"Murphy, C. A. et al. Excessive adiposity and metabolic dysfunction relate to reduced natriuretic peptide during RAAS activation in HIV. J. Clin. Endocrinol. Metab. 103, 1558\u20131565 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1349_CR29","doi-asserted-by":"publisher","first-page":"H984","DOI":"10.1152\/ajpheart.00428.2011","volume":"301","author":"EE Essick","year":"2011","unstructured":"Essick, E. E. et al. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling. Am. J. Physiol. Heart Circ. Physiol. 301, H984\u2013H993 (2011).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1349_CR30","doi-asserted-by":"publisher","first-page":"e68697","DOI":"10.1371\/journal.pone.0068697","volume":"8","author":"EE Essick","year":"2013","unstructured":"Essick, E. E. et al. Adiponectin modulates oxidative stress-induced autophagy in cardiomyocytes. PLoS One 8, e68697 (2013).","journal-title":"PLoS One"},{"key":"1349_CR31","doi-asserted-by":"publisher","first-page":"e003381","DOI":"10.1161\/CIRCHEARTFAILURE.116.003381","volume":"9","author":"M Valero-Munoz","year":"2016","unstructured":"Valero-Munoz, M. et al. Dual endothelin-A\/endothelin-B receptor blockade and cardiac remodeling in heart failure with preserved ejection fraction. Circul. Heart Fail. 9, e003381 (2016).","journal-title":"Circul. Heart Fail."},{"key":"1349_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"1349_CR33","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1349_CR34","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1349_CR35","doi-asserted-by":"publisher","first-page":"1016452","DOI":"10.3389\/fcvm.2022.1016452","volume":"9","author":"EL Saw","year":"2022","unstructured":"Saw, E. L. et al. Skeletal muscle phenotypic switching in heart failure with preserved ejection fraction. Front. Cardiovasc. Med. 9, 1016452 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"1349_CR36","doi-asserted-by":"publisher","first-page":"14386","DOI":"10.1073\/pnas.212327899","volume":"99","author":"C Twu","year":"2002","unstructured":"Twu, C. et al. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways. Proc. Natl. Acad. Sci. USA 99, 14386\u201314391 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1349_CR37","doi-asserted-by":"publisher","first-page":"966968","DOI":"10.3389\/fcvm.2022.966968","volume":"9","author":"M Valero-Mu\u00f1oz","year":"2022","unstructured":"Valero-Mu\u00f1oz, M. et al. Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF). Front. Cardiovasc. Med. 9, 966968 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"1349_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jacc.2010.10.068","volume":"58","author":"MR Zile","year":"2011","unstructured":"Zile, M. R. & Gaasch, W. H. Abnormal calcium homeostasis: one mechanism in diastolic heart failure. J. Am. Coll. Cardiol. 58, 155\u2013157 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1349_CR39","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1161\/CIRCHEARTFAILURE.114.001279","volume":"7","author":"K Tanaka","year":"2014","unstructured":"Tanaka, K. et al. Effects of adiponectin on calcium-handling proteins in heart failure with preserved ejection fraction. Circ. Heart Fail 7, 976\u2013985 (2014).","journal-title":"Circ. Heart Fail"},{"key":"1349_CR40","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.ajpath.2017.05.011","volume":"187","author":"L Prevedel","year":"2017","unstructured":"Prevedel, L., Morocho, C., Bennett, M. V. L. & Eugenin, E. A. HIV-associated cardiovascular disease: role of connexin 43. Am. J. Pathol. 187, 1960\u20131970 (2017).","journal-title":"Am. J. Pathol."},{"key":"1349_CR41","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1161\/01.CIR.98.14.1355","volume":"98","author":"LM Buja","year":"1998","unstructured":"Buja, L. M. & Entman, M. L. Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation 98, 1355\u20131357 (1998).","journal-title":"Circulation"},{"key":"1349_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12012-008-9026-y","volume":"8","author":"Y Yuan","year":"2008","unstructured":"Yuan, Y., Kan, H., Fang, Q., Chen, F. & Finkel, M. S. CXCR4 receptor antagonist blocks cardiac myocyte p38 MAP kinase phosphorylation by HIV gp120. Cardiovasc. Toxicol. 8, 173\u2013180 (2008).","journal-title":"Cardiovasc. Toxicol."},{"key":"1349_CR43","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1159\/000502238","volume":"86","author":"R Gao","year":"2019","unstructured":"Gao, R. et al. R5 HIV-1 gp120 activates p38 MAPK to induce rat cardiomyocyte injury by the CCR5 coreceptor. Pathobiology 86, 274\u2013284 (2019).","journal-title":"Pathobiology"},{"key":"1349_CR44","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.amjcard.2007.11.073","volume":"101","author":"I Schuster","year":"2008","unstructured":"Schuster, I. et al. Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy. Am. J. Cardiol. 101, 1213\u20131217 (2008).","journal-title":"Am. J. Cardiol."},{"key":"1349_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.hfc.2007.10.007","volume":"4","author":"M Periasamy","year":"2008","unstructured":"Periasamy, M. & Janssen, P. M. Molecular basis of diastolic dysfunction. Heart Fail Clin. 4, 13\u201321 (2008).","journal-title":"Heart Fail Clin."},{"key":"1349_CR46","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.111.259754","volume":"110","author":"EG Kranias","year":"2012","unstructured":"Kranias, E. G. & Hajjar, R. J. Modulation of cardiac contractility by the phospholamban\/SERCA2a regulatome. Circ. Res 110, 1646\u20131660 (2012).","journal-title":"Circ. Res"},{"key":"1349_CR47","doi-asserted-by":"publisher","first-page":"H1146","DOI":"10.1152\/ajpheart.00720.2003","volume":"286","author":"JELJ Schultz","year":"2004","unstructured":"Schultz, J. E. L. J. et al. Accelerated onset of heart failure in mice during pressure overload with chronically decreased SERCA2 calcium pump activity. Am. J. Physiol. Heart Circ. Physiol. 286, H1146\u2013H1153 (2004).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1349_CR48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/labinvest.3780022","volume":"80","author":"W Lewis","year":"2000","unstructured":"Lewis, W. et al. Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine. Lab Invest 80, 187\u2013197 (2000).","journal-title":"Lab Invest"},{"key":"1349_CR49","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1016\/j.ijcard.2013.04.128","volume":"168","author":"KM Reyskens","year":"2013","unstructured":"Reyskens, K. M. & Essop, M. F. The maladaptive effects of HIV protease inhibitors (lopinavir\/ritonavir) on the rat heart. Int J. Cardiol. 168, 3047\u20133049 (2013).","journal-title":"Int J. Cardiol."},{"key":"1349_CR50","doi-asserted-by":"publisher","first-page":"e73347","DOI":"10.1371\/journal.pone.0073347","volume":"8","author":"KM Reyskens","year":"2013","unstructured":"Reyskens, K. M. et al. Cardio-metabolic effectsof HIV protease inhibitors (lopinavir\/ritonavir). PLoS One 8, e73347 (2013).","journal-title":"PLoS One"},{"key":"1349_CR51","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrm1151","volume":"4","author":"DH MacLennan","year":"2003","unstructured":"MacLennan, D. H. & Kranias, E. G. Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol. 4, 566\u2013577 (2003).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1349_CR52","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.yjmcc.2014.10.005","volume":"77","author":"K Haghighi","year":"2014","unstructured":"Haghighi, K., Bidwell, P. & Kranias, E. G. Phospholamban interactome in cardiac contractility and survival: A new vision of an old friend. J. Mol. Cell Cardiol. 77, 160\u2013167 (2014).","journal-title":"J. Mol. Cell Cardiol."},{"key":"1349_CR53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cmet.2015.01.005","volume":"21","author":"PA Gorski","year":"2015","unstructured":"Gorski, P. A., Ceholski, D. K. & Hajjar, R. J. Altered myocardial calcium cycling and energetics in heart failure-a rational approach for disease treatment. Cell Metab. 21, 183\u2013194 (2015).","journal-title":"Cell Metab."},{"key":"1349_CR54","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1161\/01.RES.0000164359.95588.25","volume":"96","author":"HC Champion","year":"2005","unstructured":"Champion, H. C. Targeting protein phosphatase 1 in heart failure. Circ. Res. 96, 708\u2013710 (2005).","journal-title":"Circ. Res."},{"key":"1349_CR55","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cardfail.2018.02.001","volume":"24","author":"J Butler","year":"2018","unstructured":"Butler, J. et al. Diastolic dysfunction in individuals with human immunodeficiency virus infection: literature review, rationale and design of the characterizing heart function on antiretroviral therapy (CHART) Study. J. Card. Fail 24, 255\u2013265 (2018).","journal-title":"J. Card. Fail"},{"key":"1349_CR56","doi-asserted-by":"publisher","first-page":"e004091","DOI":"10.1161\/CIRCIMAGING.115.004091","volume":"9","author":"JA Luetkens","year":"2016","unstructured":"Luetkens, J. A. et al. Cardiac magnetic resonance reveals signs of subclinical myocardial inflammation in asymptomatic HIV-infected patients. Circ. Cardiovasc. Imaging 9, e004091 (2016).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"1349_CR57","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cardfail.2019.10.011","volume":"26","author":"J Butler","year":"2020","unstructured":"Butler, J. et al. Diastolic dysfunction in patients with human immunodeficiency virus receiving antiretroviral therapy: results from the CHART study. J. Card. Fail 26, 371\u2013380 (2020).","journal-title":"J. Card. Fail"},{"key":"1349_CR58","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","volume":"117","author":"NG Frangogiannis","year":"2021","unstructured":"Frangogiannis, N. G. Cardiac fibrosis. Cardiovasc Res 117, 1450\u20131488 (2021).","journal-title":"Cardiovasc Res"},{"key":"1349_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.yjmcc.2016.03.005","volume":"94","author":"J Pellman","year":"2016","unstructured":"Pellman, J., Zhang, J. & Sheikh, F. Myocyte-fibroblast communication in cardiac fibrosis and arrhythmias: mechanisms and model systems. J. Mol. Cell Cardiol. 94, 22\u201331 (2016).","journal-title":"J. Mol. Cell Cardiol."},{"key":"1349_CR60","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1152\/physrev.00008.2011","volume":"92","author":"NG Frangogiannis","year":"2012","unstructured":"Frangogiannis, N. G. Matricellular proteins in cardiac adaptation and disease. Physiol. Rev. 92, 635\u2013688 (2012).","journal-title":"Physiol. Rev."},{"key":"1349_CR61","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1159\/000490077","volume":"47","author":"H Shen","year":"2018","unstructured":"Shen, H. et al. Activation of TGF-\u03b21\/\u03b1-SMA\/Col I profibrotic pathway in fibroblasts by galectin-3 contributes to atrial fibrosis in experimental models and patients. Cell Physiol. Biochem. 47, 851\u2013863 (2018).","journal-title":"Cell Physiol. Biochem."},{"key":"1349_CR62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/cvr\/cvv214","volume":"109","author":"J Gonz\u00e1lez-Santamar\u00eda","year":"2015","unstructured":"Gonz\u00e1lez-Santamar\u00eda, J. et al. Matrix cross-linking lysyl oxidases are induced in response to myocardial infarction and promote cardiac dysfunction. Cardiovasc. Res. 109, 67\u201378 (2015).","journal-title":"Cardiovasc. Res."},{"key":"1349_CR63","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1091\/mbc.E16-01-0038","volume":"27","author":"AK Peter","year":"2016","unstructured":"Peter, A. K., Bjerke, M. A. & Leinwand, L. A. Biology of the cardiac myocyte in heart disease. Mol. Biol. Cell 27, 2149\u20132160 (2016).","journal-title":"Mol. Biol. Cell"},{"key":"1349_CR64","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.yjmcc.2019.09.006","volume":"136","author":"B Liu","year":"2019","unstructured":"Liu, B. et al. Comparative study on isolation and mitochondrial function of adult mouse and rat cardiomyocytes. J. Mol. Cell Cardiol. 136, 64\u201371 (2019).","journal-title":"J. Mol. Cell Cardiol."},{"key":"1349_CR65","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/infdis\/jiaa196","volume":"222","author":"C deFilippi","year":"2020","unstructured":"deFilippi, C. et al. Differential plasma protein regulation and statin effects in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients utilizing a proteomics approach. J. Infect. Dis. 222, 929\u2013939 (2020).","journal-title":"J. Infect. Dis."},{"key":"1349_CR66","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s11904-019-00442-9","volume":"16","author":"E Bowman","year":"2019","unstructured":"Bowman, E. & Funderburg, N. T. Lipidome abnormalities and cardiovascular disease risk in HIV infection. Curr. HIV\/AIDS Rep. 16, 214\u2013223 (2019).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"1349_CR67","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1089\/aid.2013.0280","volume":"30","author":"M Troseid","year":"2014","unstructured":"Troseid, M. et al. Microbial translocation and cardiometabolic risk factors in HIV infection. AIDS Res Hum. Retroviruses 30, 514\u2013522 (2014).","journal-title":"AIDS Res Hum. Retroviruses"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01349-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01349-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01349-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T14:05:10Z","timestamp":1770300310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01349-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1349"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-01349-w","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.S. is a full-time employee of Eli Lilly and Co, Indianapolis. None of the work was funded nor supported by Eli Lilly and Co. F.S. has no other conflicts to disclose regarding the work in this manuscript. M.V.Z. is Principal Investigator on an Investigator-initiated research grant from Gilead to her institution (MGH), unrelated to the work in this manuscript. S.K.G. has received research support from Kowa Pharmaceuticals, Viiv and Gilead unrelated to this manuscript. He serves on the Advisory Boards of Exavir Therapeutics and Marathon Asset Management unrelated to this manuscript. The remaining authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}